Its mechanism of action is to inhibit breast cancer cell migration, reduce cell stemness, induce apoptosis, and stimulate cell cycle arrest by targeting MLK3, and the results of studies suggest that compound 4 is a potential therapeutic agent for triple-negative breast cancer. This evidence concerns the gene MAP3K11 and breast cancer.